Annual report pursuant to Section 13 and 15(d)

Equity (Details)

v3.7.0.1
Equity (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Shares, Outstanding Balance 200,000  
Number of Shares, Granted 460,000 200,000
Number of Shares, Cancelled (150,000)  
Number of Shares, Outstanding Balance 510,000 200,000
Number of Shares, Exercisable 50,000  
Weighted Average Grant Date Fair Value, Outstanding Balance $ 0.14  
Weighted Average Grant Date Fair Value, Granted 3.75 $ 0.14
Weighted Average Grant Date Fair Value, Cancelled 0.14  
Weighted Average Grant Date Fair Value, Outstanding Balance 3.40 0.14
Weighted Average Grant Date Fair Value, Exercisable 0.14  
Weighted Average Exercise Price, Outstanding Balance 0.2  
Weighted Average Exercise Price, Granted 5.83 0.20
Weighted Average Exercise Price, Cancelled 0.2  
Weighted Average Exercise Price, Outstanding Balance 5.28 $ 0.2
Weighted Average Exercise Price, Exercisable $ 0.2  
Weighted Average Remaining Contractual Term (in years), Outstanding 9 years 3 months 14 days  
Weighted Average Remaining Contractual Term (in years), Exercisable 3 years 8 months 1 day  
Aggregate Intrinsic Value, Outstanding Balance $ 275,500  
Aggregate Intrinsic Value, Exercisable $ 275,500